OpenBilldrug price receipt

NADAC week of 2026-10-14

RELEXXII ER 36 MG TABLET

FDA nonproprietary name: methylphenidate hydrochloride

For 30 tablets

Pharmacies pay

$352.28 filed

30 × $11.74277 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$410.12 estimated

$352.28 + $52.84 (15%) + $5.00 fee per fill = $410.12

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

RELEXXII ER 36 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as methylphenidate hydrochloride, under the trade name “RELEXXII”.

FDA gives its dosage form as tablet, extended release and its route as oral.

The labeler, the company named on the label, is Vertical Pharmaceuticals, LLC.

FDA’s Established Pharmacologic Class for it is Central Nervous System Stimulant.

The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $352.28 for 30 tablets (30 × $11.74277 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

All 2 NDCs

Other strengths, forms and brands

59 other products in the NADAC file share the FDA nonproprietary name methylphenidate hydrochloride with RELEXXII ER 36 MG TABLET. The 23 below share a strength or dosage form with it first; search OpenBill for the rest.

ProductPharmacies pay per unitMedicare per unit
CONCERTA ER 18 MG TABLET
brand · tablet, extended release
$12.32528 per EA filed
eff. 2026-09-23
We don’t know yet
CONCERTA ER 27 MG TABLET
brand · tablet, extended release
$12.65426 per EA filed
eff. 2026-09-23
We don’t know yet
CONCERTA ER 36 MG TABLET
brand · tablet, extended release
$13.04275 per EA filed
eff. 2026-09-23
We don’t know yet
CONCERTA ER 54 MG TABLET
brand · tablet, extended release
$14.17967 per EA filed
eff. 2026-09-23
We don’t know yet
JORNAY PM 20 MG CAPSULE
brand · capsule
$15.39302 per EA filed
eff. 2026-09-23
$15.06416 per EA filed
Part D 2024 average
JORNAY PM 40 MG CAPSULE
brand · capsule
$15.40511 per EA filed
eff. 2026-09-23
$15.06416 per EA filed
Part D 2024 average
JORNAY PM 60 MG CAPSULE
brand · capsule
$15.40191 per EA filed
eff. 2026-09-23
$15.06416 per EA filed
Part D 2024 average
JORNAY PM 80 MG CAPSULE
brand · capsule
$15.40151 per EA filed
eff. 2026-09-23
$15.06416 per EA filed
Part D 2024 average
JORNAY PM 100 MG CAPSULE
brand · capsule
$15.39596 per EA filed
eff. 2026-09-23
$15.06416 per EA filed
Part D 2024 average
METHYLPHENIDATE ER 10 MG TAB
generic · tablet, extended release / tablet
$0.45832 per EA filed
eff. 2026-09-23
$2.28047 per EA filed
Part D 2024 average
METHYLPHENIDATE ER 18 MG TAB
generic · tablet, extended release / tablet, film coated, extended release
$0.5761 per EA filed
eff. 2026-09-23
$2.28047 per EA filed
Part D 2024 average
METHYLPHENIDATE ER 20 MG TAB
generic · tablet, extended release / tablet
$0.51315 per EA filed
eff. 2026-09-23
$2.28047 per EA filed
Part D 2024 average
METHYLPHENIDATE ER 27 MG TAB
generic · tablet, extended release / tablet, film coated, extended release
$0.67661 per EA filed
eff. 2026-09-23
$2.28047 per EA filed
Part D 2024 average
METHYLPHENIDATE ER 36 MG TAB
generic · tablet, extended release / tablet, film coated, extended release
$0.67155 per EA filed
eff. 2026-09-23
$2.28047 per EA filed
Part D 2024 average
METHYLPHENIDATE ER 45 MG TAB
generic · tablet, extended release
$17.50602 per EA filed
eff. 2026-09-23
$2.28047 per EA filed
Part D 2024 average
METHYLPHENIDATE ER 54 MG TAB
generic · tablet, extended release / tablet, film coated, extended release
$0.80506 per EA filed
eff. 2026-09-23
$2.28047 per EA filed
Part D 2024 average
METHYLPHENIDATE ER 63 MG TAB
generic · tablet, extended release
$18.87437 per EA filed
eff. 2026-09-23
$2.28047 per EA filed
Part D 2024 average
METHYLPHENIDATE ER 72 MG TAB
generic · tablet, extended release
$16.50883 per EA filed
eff. 2026-09-23
$2.28047 per EA filed
Part D 2024 average
RELEXXII ER 18 MG TABLET
brand · tablet, extended release
$10.94478 per EA filed
eff. 2026-09-23
We don’t know yet
RELEXXII ER 27 MG TABLET
brand · tablet, extended release
$11.32467 per EA filed
eff. 2026-09-23
We don’t know yet
RELEXXII ER 36 MG TABLET this page
brand · tablet, extended release
$11.74277 per EA filed
eff. 2026-09-23
We don’t know yet
RELEXXII ER 54 MG TABLET
brand · tablet, extended release
$12.77792 per EA filed
eff. 2026-03-18
We don’t know yet
RELEXXII ER 63 MG TABLET
brand · tablet, extended release
$21.35259 per EA filed
eff. 2026-09-23
We don’t know yet
RELEXXII ER 72 MG TABLET
brand · tablet, extended release
$22.0992 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-03-18, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 2 NDCs’ NADAC prices is $11.74277 per EA filed.

Of the 203 other products in FDA’s Central Nervous System Stimulant class priced per EA, 63 have a higher middle NADAC price and 140 a lower one. The one in the middle is LISDEXAMFETAMINE 20 MG TB CHEW, at $4.33791 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.